Target intelligence / Profile preview

No specific pharmacologic target

Molecular classification
Other
01

Overview

The designation 'No specific pharmacologic target' refers to a category of therapeutic agents that achieve their clinical effect through non-specific physical or chemical mechanisms rather than by binding to a specific biological macromolecule like a receptor, enzyme, or ion channel (DrugBank Online). Common examples include antacids, such as magnesium hydroxide, which neutralize gastric acid via simple chemical reactions (StatPearls, 'Antacids'). Osmotic agents, including mannitol and polyethylene glycol, create an osmotic gradient that shifts water across biological membranes, which is useful in treating cerebral edema or constipation (StatPearls, 'Osmotic Diuretics'). Additionally, agents like activated charcoal work through the physical adsorption of substances within the gastrointestinal tract to prevent systemic absorption (NCBI, 'Activated Charcoal'). Because these substances do not target a specific protein, they do not follow traditional receptor-mediated pharmacodynamics or structure-activity relationships. This classification is used to identify drugs whose mechanism of action is based on broad physiological or chemical changes rather than high-affinity molecular interactions. Consequently, these agents often have different safety profiles, such as risks of electrolyte imbalance, compared to targeted molecular therapies. This category is essential for pharmacological databases to accurately categorize drugs that modify the physiological environment through broad, non-targeted actions.

Other names
Non-specific targetNon-molecular targetPhysical/Chemical mechanismNon-specific action
02

Mechanism of action

Non-specific physical or chemical interactions, including acid-base neutralization, osmotic gradient formation, and physical adsorption.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Electrolyte imbalanceDehydrationInterference with absorption of other drugs
06

Interacting drugs

Aluminum hydroxide

7 more in the full profile.

Beyond the preview

Go deeper on No specific pharmacologic target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No specific pharmacologic target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call